NASDAQ:BVXV
BiondVax Pharmaceuticals Ltd.
- Stock
Last Close
1.35
06/09 19:59
Market Cap
4.97M
Beta: 2.47
Volume Today
22.67K
Avg: 41.50K
PE Ratio
0.59
PFCF: −3.53
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.03 - | ||||||||||
cash per share | 60.83 - | 35.59 41.50% | 134.52 277.98% | 52.47 60.99% | 142.03 170.68% | 30.83 78.29% | 88.74 187.84% | 2.64 97.02% | 38.28 1,348.03% | 7.47 80.50% | |
company equity multiplier | 1.08 - | 1.11 3.39% | 1.23 10.63% | 1.18 4.54% | 1.45 23.55% | -3.39 333.46% | -1.78 47.52% | -3.90 119.13% | 4.27 209.48% | -15.38 460.28% | |
days of inventory outstanding | |||||||||||
days of payables outstanding | |||||||||||
days of sales outstanding | 40.64 - | ||||||||||
dividend yield | |||||||||||
ebit per revenue | -12.67 - | ||||||||||
ebt per ebit | 1.05 - | 0.95 9.33% | 0.90 5.37% | 0.77 14.47% | 1.46 89.25% | 1.14 22.06% | 1.39 22.43% | -1.33 195.60% | 1.15 186.16% | 0.52 54.35% | |
effective tax rate | 0.00 - | 0.01 455.26% | -0.32 5,365.45% | -0.12 60.72% | -0.14 10.31% | 5.92 4,432.54% | -0.27 104.58% | 0.91 435.26% | |||
enterprise value multiple | -5.58 - | -7.22 29.37% | -0.68 90.62% | -2.46 263.61% | -2.02 17.95% | -6.21 207.00% | -4.18 32.67% | 33.95 912.22% | -3.66 110.77% | -1.24 66.02% | |
fixed asset turnover | 0.06 - | ||||||||||
free cash flow per share | -13.47 - | -23.27 72.73% | -39.05 67.83% | -28.64 26.65% | -28.97 1.14% | -123.82 327.46% | -103.46 16.45% | -70.99 31.38% | -17.65 75.14% | -4.30 75.66% | |
gross profit margin | 1 - | ||||||||||
interest coverage | -5.67 - | -5.25 7.34% | 0.21 104.07% | -3.22 1,603.11% | 2.10 165.34% | ||||||
inventory turnover | |||||||||||
long term debt to capitalization | 1.49 - | 1.99 33.35% | -0.72 135.91% | 0.75 204.42% | 1.09 45.98% | ||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1.14 13.66% | -4.92 532.78% | 1.27 125.84% | 0.09 92.79% | |
net profit margin | -18.49 - | ||||||||||
operating cash flow per share | -12.87 - | -23.17 80.07% | -38.92 67.94% | -28.58 26.56% | -20.00 30.03% | -87.51 337.62% | -94.36 7.83% | -65.46 30.63% | -17.35 73.50% | -3.85 77.78% | |
operating profit margin | -12.67 - | ||||||||||
payables turnover | |||||||||||
pretax profit margin | -14.55 - | ||||||||||
price fair value | 2.36 - | 3.83 62.41% | 1.21 68.32% | 1.70 39.95% | 1.71 0.76% | -14.15 927.00% | -4.03 71.49% | -22.04 446.35% | 4.41 120.02% | -3.17 171.85% | |
receivables turnover | 8.98 - | ||||||||||
return on assets | -0.31 - | -0.42 35.14% | -0.25 41.29% | -0.31 23.53% | -0.42 38.66% | -0.83 95.99% | -1.07 29.36% | 0.39 135.91% | -0.51 232.48% | -0.02 96.15% | |
return on capital employed | -0.32 - | -0.49 53.87% | -0.29 41.65% | -0.41 45.12% | -0.32 23.65% | -0.92 190.02% | -0.81 11.73% | -0.46 43.24% | -0.38 17.95% | -0.45 18.65% | |
return on equity | -0.34 - | -0.47 39.71% | -0.30 35.05% | -0.36 17.92% | -0.61 71.32% | 2.81 557.56% | 1.91 32.11% | -1.50 178.70% | -2.18 45.04% | 0.30 113.85% | |
total debt to capitalization | 1.49 - | 1.98 32.65% | 1.28 35.54% | 0.75 41.35% | 1.09 45.33% |
All numbers in USD (except ratios and percentages)